Drugs News and Research

RSS

Researchers study effective ways to get medicine into the brain for treating neurological diseases

A big challenge in medical science is to get medicine into the brain when treating patients with neurological diseases. The brain will do everything to keep foreign substances out and therefore the brains of neurological patients fight a constant, daily battle to throw out the medicine prescribed to help the patients.

26 Sep 2013

Results of NovaRx's Lucanix Phase III trial in non-small cell lung cancer to be presented at ESMO 2013

NovaRx Corporation announced that the detailed results from the randomized Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer will be presented at the European Society for Medical Oncology 2013 annual meeting in Amsterdam.

26 Sep 2013

Lawmakers weigh deal giving FDA reater clout after meningitis outbreak

House and Senate negotiators appear to be making progress towards stiffer regulations over the type of drugs that caused last year's outbreak. In other Capitol Hill news, the GOP pushes to repeal a tax on medical devices, and rural health care providers ask for more time to meet electronic health record deadlines.

26 Sep 2013

Ten health care innovations could save lives of mothers and children

Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015.

26 Sep 2013

Drug use associated with increased risk of fatal crash involvement

Drugged driving has been a safety issue of increasing public concern in the United States and many other countries but its role in motor vehicle crashes had not been adequately examined. In a new study conducted at Columbia University's Mailman School of Public Health, researchers assessed the association of driver drug use, as well as the combination of drugs and alcohol, with the risk of fatal crash.

26 Sep 2013

Research shows commonly prescribed statin medicines can adversely affect cognitive function

New research that looked at whether two commonly prescribed statin medicines, used to lower low-density lipoprotein (LDL) or 'bad cholesterol' levels in the blood, can adversely affect cognitive function has found that one of the drugs tested caused memory impairment in rats.

26 Sep 2013

Targeting cell-division cycle may lead to improved outcomes for patients with medulloblastoma

A new experimental approach to treating a type of brain cancer called medulloblastoma has been developed by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham).

26 Sep 2013

Copenhagen researchers gain insight in molecular mechanisms behind breast cancer metastasis

Researchers at University of Copenhagen have gained more insight into the molecular mechanisms of importance for, for example, cancer cell growth and metastasis. The research objective is improved and more targeted drugs. The findings have just been published in the scientific journal Molecular Cell.

26 Sep 2013

Janssen signs license agreement with PATH for early development HIV-1 medicine rilpivirine

Janssen R&D Ireland announced today it has signed a license agreement with PATH for the early development of the human immunodeficiency virus type 1 medicine rilpivirine in a long-acting injection (depot formulation) as potential pre-exposure prophylaxis against HIV infection.

25 Sep 2013

Exposure to cocaine during in utero development causes disruptions in normal brain development

Prenatal cocaine exposure affects both behavior and brain. Animal studies have shown that exposure to cocaine during in utero development causes numerous disruptions in normal brain development and negatively affects behavior from birth and into adulthood.

25 Sep 2013

UCSF inaugurates new endowment of PhD education programs in basic sciences

Sequoia Capital Chairman Sir Michael Moritz, KBE, and his wife, Harriet Heyman, in collaboration with UC San Francisco, have kicked off a new endowment with a $60 million contribution to ensure the future of PhD education programs in the basic sciences.

25 Sep 2013

Study on tempol impacted gut bacteria may lead to new treatments for obesity

A drug that appears to target specific intestinal bacteria in the guts of mice may create a chain reaction that could eventually lead to new treatments for obesity and diabetes in humans, according to a team of researchers.

25 Sep 2013

Researchers identify molecular pathway linking ICU ventilation to brain damage

At least 30 percent of patients in intensive care units (ICUs) suffer some form of mental dysfunction as reflected in anxiety, depression, and especially delirium. In mechanically-ventilated ICU patients, the incidence of delirium is particularly high, about 80 percent, and may be due in part to damage in the hippocampus, though how ventilation is increasing the risk of damage and mental impairment has remained elusive.

25 Sep 2013

Proton therapy reduces treatment side effects among head and neck cancer patients

The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania.

25 Sep 2013

Cerebral imaging in patients with early symptoms of AD may have better clinical outcomes

Patients suffering from early symptoms of Alzheimer's disease who were diagnosed sooner than usual using a brain imaging test received Alzheimer-specific medications earlier than those who did not have the brain imaging results available to their doctors or themselves.

25 Sep 2013

Study shows how deadly Candida albicans might be rendered harmless

Candida albicans is a double agent: In most of us, it lives peacefully, but for people whose immune systems are compromised by HIV or other severe illnesses, it is frequently deadly. Now a new study from Johns Hopkins and Harvard Medical School shows how targeting a specific fungal component might turn the fungus from a lion back into a kitten.

25 Sep 2013

Quartette tablets now available in U.S. for prevention of pregnancy

Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.

24 Sep 2013

First Direct Measurement Of Spinal Cord Myelin In MS

...

24 Sep 2013

Abbvie, Galapagos Ink Up To $405M CF Collaboration

...

24 Sep 2013

NeoTract treats first patient in US with UroLift System

NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia in men 50 years of age or older.

24 Sep 2013

Drugs News and Research

Researchers study effective ways to get medicine into the brain for treating neurological diseases

Results of NovaRx's Lucanix Phase III trial in non-small cell lung cancer to be presented at ESMO 2013

Lawmakers weigh deal giving FDA reater clout after meningitis outbreak

Ten health care innovations could save lives of mothers and children

Drug use associated with increased risk of fatal crash involvement

Research shows commonly prescribed statin medicines can adversely affect cognitive function

Targeting cell-division cycle may lead to improved outcomes for patients with medulloblastoma

Copenhagen researchers gain insight in molecular mechanisms behind breast cancer metastasis

Janssen signs license agreement with PATH for early development HIV-1 medicine rilpivirine

Exposure to cocaine during in utero development causes disruptions in normal brain development

UCSF inaugurates new endowment of PhD education programs in basic sciences

Study on tempol impacted gut bacteria may lead to new treatments for obesity

Researchers identify molecular pathway linking ICU ventilation to brain damage

Proton therapy reduces treatment side effects among head and neck cancer patients

Cerebral imaging in patients with early symptoms of AD may have better clinical outcomes

Study shows how deadly Candida albicans might be rendered harmless

Quartette tablets now available in U.S. for prevention of pregnancy

First Direct Measurement Of Spinal Cord Myelin In MS

Abbvie, Galapagos Ink Up To $405M CF Collaboration

NeoTract treats first patient in US with UroLift System

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News